Literature DB >> 10869234

A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families.

P Ciotti1, J P Struewing, M Mantelli, A Chompret, M F Avril, P L Santi, M A Tucker, G Bianchi-Scarrà, B Bressac-de Paillerets, A M Goldstein.   

Abstract

Germline mutations within the coding region of CDKN2A have been observed in affected members of melanoma-prone families. G101W is the most common CDKN2A missense mutation identified to date. It has been reported in several families from around the world, with a particularly high occurrence in France and Italy. Given the frequency of this mutation, we were interested in determining whether the mutation resulted from a single origin or represented a mutational hotspot in the CDKN2A gene. In addition, given the geographical distribution of the mutation, we examined the date of origination of the mutation and its migratory spread. We examined 10 families from Italy, 4 families from the United States, and 6 families from France with the G101W mutation. The following eight markers were employed for the haplotype analysis: IFNA, D9S736, D9S1749, D9S942, D9S1748, D9S1604, D9S171, and D9S126. Our findings showed no significant evidence for mutational heterogeneity, suggesting that all studied families derived from a single ancestral haplotype on which the mutation arose. Using maximum-likelihood methods, we estimated the mutation to have arisen 97 generations ago (1-LOD-unit support interval 70-133 generations) providing some explanation for the wide geographical spread of this common mutation, particularly in southwestern Europe. The presence of a founder mutation in a defined geographic area can facilitate carrier detection and genetic counseling and can provide an opportunity to study disease penetrance and the effect of environmental factors on the background of a common genetic susceptibility.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869234      PMCID: PMC1287180          DOI: 10.1086/303001

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  30 in total

1.  Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population.

Authors:  N Risch; D de Leon; L Ozelius; P Kramer; L Almasy; B Singer; S Fahn; X Breakefield; S Bressman
Journal:  Nat Genet       Date:  1995-02       Impact factor: 38.330

2.  Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.

Authors:  A J Whelan; D Bartsch; P J Goodfellow
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

3.  Germline p16 mutations in familial melanoma.

Authors:  C J Hussussian; J P Struewing; A M Goldstein; P A Higgins; D S Ally; M D Sheahan; W H Clark; M A Tucker; N C Dracopoli
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

4.  Mutations associated with familial melanoma impair p16INK4 function.

Authors:  K Ranade; C J Hussussian; R S Sikorski; H E Varmus; A M Goldstein; M A Tucker; M Serrano; G J Hannon; D Beach; N C Dracopoli
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

5.  Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.

Authors:  S L Neuhausen; S Mazoyer; L Friedman; M Stratton; K Offit; A Caligo; G Tomlinson; L Cannon-Albright; T Bishop; D Kelsell; E Solomon; B Weber; F Couch; J Struewing; P Tonin; F Durocher; S Narod; M H Skolnick; G Lenoir; O Serova; B Ponder; D Stoppa-Lyonnet; D Easton; M C King; D E Goldgar
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

6.  Analysis of the p16 gene, CDKN2, in 17 Australian melanoma kindreds.

Authors:  E A Holland; S C Beaton; T M Becker; O M Grulet; B A Peters; H Rizos; R F Kefford; G J Mann
Journal:  Oncogene       Date:  1995-12-07       Impact factor: 9.867

7.  Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.

Authors:  G J Walker; C J Hussussian; J F Flores; J M Glendening; F G Haluska; N C Dracopoli; N K Hayward; J W Fountain
Journal:  Hum Mol Genet       Date:  1995-10       Impact factor: 6.150

8.  Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.

Authors:  A M Goldstein; M C Fraser; J P Struewing; C J Hussussian; K Ranade; D P Zametkin; L S Fontaine; S M Organic; N C Dracopoli; W H Clark
Journal:  N Engl J Med       Date:  1995-10-12       Impact factor: 91.245

9.  Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.

Authors:  A Kamb; D Shattuck-Eidens; R Eeles; Q Liu; N A Gruis; W Ding; C Hussey; T Tran; Y Miki; J Weaver-Feldhaus
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

10.  Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds.

Authors:  N A Gruis; P A van der Velden; L A Sandkuijl; D E Prins; J Weaver-Feldhaus; A Kamb; W Bergman; R R Frants
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

View more
  9 in total

Review 1.  Genetic predisposition to pancreatic cancer.

Authors:  Paola Ghiorzo
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Absence of germline CDKN2A mutation in Sicilian patients with familial malignant melanoma: Could it be a population-specific genetic signature?

Authors:  Sara Di Lorenzo; Daniele Fanale; Bartolo Corradino; Valentina Caló; Gaetana Rinaldi; Viviana Bazan; Antonio Giordano; Adriana Cordova; Antonio Russo
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

Review 3.  Familial melanoma: a complex disorder leading to controversy on DNA testing.

Authors:  Femke A de Snoo; Wilma Bergman; Nelleke A Gruis
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

4.  Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families.

Authors:  Barbara Peric; Petra Cerkovnik; Srdjan Novakovic; Janez Zgajnar; Nikola Besic; Marko Hocevar
Journal:  BMC Med Genet       Date:  2008-09-19       Impact factor: 2.103

5.  A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families.

Authors:  A M Goldstein; L Liu; M G Shennan; D Hogg; M A Tucker; J P Struewing
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

6.  Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma.

Authors:  Susana Puig; Miriam Potrony; Francisco Cuellar; Joan Anton Puig-Butille; Cristina Carrera; Paula Aguilera; Eduardo Nagore; Zaida Garcia-Casado; Celia Requena; Rajiv Kumar; Gilles Landman; Bianca Costa Soares de Sá; Gisele Gargantini Rezze; Luciana Facure; Alexandre Leon Ribeiro de Avila; Maria Isabel Achatz; Dirce Maria Carraro; João Pedreira Duprat Neto; Thais C Grazziotin; Renan R Bonamigo; Maria Carolina W Rey; Claudia Balestrini; Enrique Morales; Montserrat Molgo; Renato Marchiori Bakos; Patricia Ashton-Prolla; Roberto Giugliani; Alejandra Larre Borges; Virginia Barquet; Javiera Pérez; Miguel Martínez; Horacio Cabo; Emilia Cohen Sabban; Clara Latorre; Blanca Carlos-Ortega; Julio C Salas-Alanis; Roger Gonzalez; Zulema Olazaran; Josep Malvehy; Celia Badenas
Journal:  Genet Med       Date:  2015-12-17       Impact factor: 8.822

7.  Multiplex melanoma families are enriched for polygenic risk.

Authors:  Matthew H Law; Lauren G Aoude; David L Duffy; Georgina V Long; Peter A Johansson; Antonia L Pritchard; Kiarash Khosrotehrani; Graham J Mann; Grant W Montgomery; Mark M Iles; Anne E Cust; Jane M Palmer; Kerwin F Shannon; Andrew J Spillane; Jonathan R Stretch; John F Thompson; Robyn P M Saw; Richard A Scolyer; Nicholas G Martin; Nicholas K Hayward; Stuart MacGregor
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

8.  The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma.

Authors:  F Lesueur; M de Lichy; M Barrois; G Durand; J Bombled; M-F Avril; A Chompret; F Boitier; G M Lenoir; B Bressac-de Paillerets; Monique Baccard; Bertrand Bachollet; Pascaline Berthet; Valérie Bonadona; Jean-Marie Bonnetblanc; Olivier Caron; Jacqueline Chevrant-Breton; Jean-François Cuny; Stéphane Dalle; Michèle Delaunay; Liliane Demange; Julie De Quatrebarbes; Jean-François Doré; Marc Frénay; Jean-Pierre Fricker; Marion Gauthier-Villars; Paul Gesta; Sophie Giraud; Philippe Gorry; Florent Grange; Andrew Green; Laetitia Huiart; Nicolas Janin; Pascal Joly; Delphine Kérob; Christine Lasset; Dominique Leroux; Jean-Marc Limacher; Michel Longy; Sandrine Mansard; Karine Marrou; Tanguy Martin-Denavit; Christine Mateus; Eve Maubec; Laurence Olivier-Faivre; Vincent Orlandini; Pascal Pujol; Bruno Sassolas; Dominique Stoppa-Lyonnet; Luc Thomas; Pierre Vabres; Laurence Venat; Ewa Wierzbicka; Hélène Zattara
Journal:  Br J Cancer       Date:  2008-07-08       Impact factor: 7.640

9.  Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer.

Authors:  Joan Anton Puig-Butille; María José Escámez; Francisco Garcia-Garcia; Gemma Tell-Marti; Àngels Fabra; Lucía Martínez-Santamaría; Celia Badenas; Paula Aguilera; Marta Pevida; Joaquín Dopazo; Marcela del Río; Susana Puig
Journal:  Oncotarget       Date:  2014-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.